Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5677598 | 0.71 | PTPN1 (0.40) | ALDH1A1 | |
| SCHEMBL5085740 | 0.67 | TSHR (0.35) | — | |
| SCHEMBL1336762 | 0.67 | KDM4E (0.30) | ALDH1A1 | |
| SCHEMBL709852 | 0.64 | MAPT (0.39) | ALDH1A1 | |
| Biphenyl SCHEMBL3387747 | 0.61 | ALDH1A1 (0.90) | ALDH1A1 | |
| Biphenyl SCHEMBL10585997 | 0.61 | ALDH1A1 (0.90) | ALDH1A1 | |
| SCHEMBL205284 | 0.58 | — | — | |
| Biphenyl SCHEMBL28991329 | 0.58 | ALDH1A1 (0.82) | ALDH1A1 | |
| Biphenyl SCHEMBL945675 | 0.58 | ALDH1A1 (0.82) | ALDH1A1 | |
| Biphenyl SCHEMBL6546569 | 0.58 | ALDH1A1 (0.82) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196267-B1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | APEIRON SYNTHESIS SA (PL) | 2023-11-29 | — | — | EP | claimed |
| EP-3256505-B1 | CYCLIC OLEFIN RESIN COMPOSITIONS COMPRISING FUNCTIONAL ELASTOMERS | MATERIA INC (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | APEIRON SYNTHESIS S.A. (PL) | 2023-10-12 | — | — | US | claimed |
| EP-4196267-A1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | Apeiron Synthesis S.A. (PL) | 2023-06-21 | — | — | EP | claimed |
| WO-2022038121-A1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | APEIRON SYNTHESIS S.A. (PL) | 2022-02-24 | — | — | WO | claimed |
| US-20210403654-A1 | ADHESION PROMOTER COMPOSITIONS FOR CYCLIC OLEFIN RESIN COMPOSITIONS | MATERIA, INC. (US) | 2021-12-30 | — | — | US | claimed |
| EP-3353187-B1 | METAL CARBENE OLEFIN METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2021-07-21 | — | — | EP | claimed |
| US-11066434-B2 | Metal complexes comprising aniline type ligands | UMICORE AG & CO. KG | 2021-07-20 | — | — | US | claimed |
| US-20210155648-A1 | OLEFIN METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2021-05-27 | — | — | US | claimed |
| US-10907018-B2 | Adhesion promoter compositions for cyclic olefin resin compositions | MATERIA, INC. (US) | 2021-02-02 | — | — | US | claimed |
| EP-1757613-B1 | Multicoordinated metal complexes for use in metathesis reactions | TELENE SAS (FR) | 2011-01-19 | — | — | EP | claimed |
| US-7687635-B2 | Metal complexes useful in metathesis and other reactions | TELENE S.A.S. (FR) | 2010-03-30 | — | — | US | claimed |
| EP-1115491-B1 | CATALYST COMPLEX WITH PHENYLINDENYLIDENE LIGAND | UNIV NEW ORLEANS FOUNDATION (US) | 2009-08-05 | — | — | EP | claimed |
| JP-2009504401-A | — | — | 2009-02-05 | — | — | JP | claimed |
| US-20080293905-A9 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2008-11-27 | — | — | US | claimed |
| WO-2007022945-A2 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | VIACATT N.V. (BE) | 2007-03-01 | — | — | WO | claimed |
| EP-1757613-A1 | Multicoordinated metal complexes for use in metathesis reactions | Viacatt N.V. (BE) | 2007-02-28 | — | — | EP | claimed |
| US-20070043188-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | TELENE S.A.S. (FR) | 2007-02-22 | — | — | US | claimed |
| EP-1577282-A2 | Metal complexes for use in olefin methathesis and atom or group transfer reactions | Universiteit Gent (BE) | 2005-09-21 | — | — | EP | claimed |
| WO-2005082819-A2 | METAL COMPLEXES FOR USE IN OLEFIN METATHESIS AND ATOM GROUP TRANSFER REACTIONS | UNIVERSITEIT GENT (BE) | 2005-09-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | CYP4F11, CYP4F3, CYP4F12 | ALDH1A1 1063/4885 |
| US-11066434-B2 | Metal complexes comprising aniline type ligands | SQLE, SOAT1, SOAT2 | ALDH1A1 1330/4885 |
| US-20210155648-A1 | OLEFIN METATHESIS CATALYSTS | MOGAT2, SQLE, FDFT1 | ALDH1A1 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.